Drug Discovery Targeting Bromodomain-Containing Protein 4

Area of Science:

• Epigenetics and Molecular Biology
• Pharmacology and Drug Development

Background:

• BRD4 is a key epigenetic regulator controlling gene expression by interacting with acetylated histones.
• Disrupting BRD4 interactions can inhibit cancer cell proliferation and reduce inflammation.

Purpose of the Study:

• To summarize advances in the discovery and development of BRD4 inhibitors.
• To highlight their therapeutic potential for various human diseases.

Main Methods:

• Review of existing literature on BRD4 inhibitors.
• Analysis of chemotypes, in vitro/in vivo activity, selectivity, and mechanisms of action.

Main Results:

• Numerous BRD4 inhibitors have been developed, with several entering clinical trials.
• The review covers diverse aspects of BRD4 inhibitor research.

Conclusions:

• BRD4 inhibitors represent a promising therapeutic strategy.
• Further research is needed to overcome challenges in developing selective and effective inhibitors.